Drug Type Small molecule drug |
Synonyms- |
Target |
Action stimulants |
Mechanism SMN2 stimulants(Survival motor neuron protein stimulants) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC21H24FN5O |
InChIKeyGYKIQIOWVKCVBP-UHFFFAOYSA-N |
CAS Registry1005501-84-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Spinal Muscular Atrophy | Preclinical | United States | 14 Feb 2008 |